
Cellectar Biosciences, Inc.
CLRBNasdaqCIK 1279704HealthcareFiscal year ends Dec 31
Reports and events: 532 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-07-2306:45 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-081680 |
| 2024-07-2206:45 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-081307 |
| 2024-07-1117:15 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001104659-24-079262 |
| 2024-06-2516:09 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001104659-24-074747 |
| 2024-06-1417:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-24-071822 |
| 2024-05-1406:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-060865 |
| 2024-05-1406:32 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001410578-24-000771 |
| 2024-04-2616:58 ET | DEF 14A | Proxy statementPeriod 2024-06-14 | 0001104659-24-053057 |
| 2024-04-0117:00 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0001104659-24-041930 |
| 2024-03-2706:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-039341 |
| 2024-03-2706:30 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001410578-24-000307 |
| 2024-02-0206:03 ET | 8-K | 8.01 Other events | 0001104659-24-009664 |
| 2024-01-2516:30 ET | 8-K | 8.01 Other events | 0001104659-24-006709 |
| 2024-01-0906:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-002401 |
| 2023-11-2916:31 ET | 8-K | 8.01 Other events | 0001104659-23-122057 |
| 2023-11-1306:30 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001410578-23-002341 |
| 2023-11-0207:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-113593 |
| 2023-10-2716:40 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-112202 |
| 2023-10-0216:40 ET | DEF 14A | Proxy statementPeriod 2023-10-25 | 0001104659-23-105926 |
| 2023-09-0817:17 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-23-099368 |
| 2023-08-2116:30 ET | 8-K | 3.01 Delisting notice | 0001104659-23-093947 |
| 2023-08-1408:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-091006 |
| 2023-08-1408:30 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001410578-23-001833 |
| 2023-06-2916:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-076346 |
| 2023-06-2906:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-23-075997 |
| 2023-06-2006:08 ET | 8-K/A | 8.01 Other events | 0001104659-23-072483 |
| 2023-06-1416:25 ET | 8-K | 8.01 Other events | 0001104659-23-071211 |
| 2023-06-1316:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-070826 |
| 2023-05-0408:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-055815 |
| 2023-05-0408:31 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001410578-23-000875 |
| 2023-04-2816:15 ET | DEF 14A | Proxy statementPeriod 2023-06-14 | 0001104659-23-052980 |
| 2023-03-1616:36 ET | 10-K/A | Annual report, amendedPeriod 2022-12-31 | 0001104659-23-033350 |
| 2023-03-0908:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-030354 |
| 2023-03-0908:35 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001410578-23-000224 |
| 2023-01-0407:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001104659-23-000616 |
| 2022-12-0217:23 ET | 8-K | 1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-22-124193 |
| 2022-11-2316:20 ET | S-1 | Registration statement | 0001104659-22-121762 |
| 2022-11-0308:45 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001410578-22-002920 |
| 2022-11-0308:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-22-114234 |
| 2022-10-2517:03 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-22-111217 |
| 2022-09-2208:45 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-22-102181 |
| 2022-09-1308:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-22-099483 |
| 2022-08-0508:46 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001410578-22-002052 |
| 2022-08-0508:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-22-086472 |
| 2022-07-2116:30 ET | 8-K | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-22-081598 |
| 2022-06-2716:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-22-074774 |
| 2022-06-0719:18 ET | 8-K | 8.01 Other events | 0001104659-22-068653 |
| 2022-05-1008:45 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001410578-22-001231 |
| 2022-05-1008:41 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-22-057982 |
| 2022-05-0616:01 ET | 8-K | 3.01 Delisting notice | 0001104659-22-056977 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 16:55 ET. Listed shows no prices and gives no investment advice.